Elevance Health, Inc. (ELV) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

Elevance Health, Inc. (ELV) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

Seeking Alpha • Jun 11, 2026

Elevance Health: Making The Bull Case For Ongoing Recovery (Rating Upgrade)

Elevance Health, Inc. has rebounded ~34% from its March lows, supported by sector recovery and improved Q1 2026 results. Q1 2026 saw ELV revenue up 1.5% to $49.5bn, adjusted EPS up 5.1% to $12.58, and a benefit expense ratio improvement to 86.8%. ELV raised 2026 adjusted EPS guidance to at least $26.75 and expects a return to 12% adjusted EPS growth in 2027.

Seeking Alpha • Jun 1, 2026

Elevance Health Expands Access to Digital Tools, Helping Bridge the Healthcare Digital Divide

INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health is advancing its commitment to improving healthcare access by addressing one of healthcare's most pressing challenges: the digital divide. Through innovative programs like Get Connected for Health and services offered by CareBridge, a subsidiary of Elevance Health, the company is helping ensure that individuals - especially those in underserved communities - have the tools, connectivity, and support needed to help them better manage their healthcar.

Business Wire • May 27, 2026

Elevance Health (ELV) Up 12.6% Since Last Earnings Report: Can It Continue?

Elevance Health (ELV) reported earnings 30 days ago. What's next for the stock?

Zacks Investment Research • May 22, 2026

U.S. Health Insurers Raise EPS Estimates After Strong Q1'26, Higher Medicare Rates

The first quarter proved to be a boon for many major US managed care insurers, as earnings results exceeded consensus estimates, leading to rises in stock prices and higher full-year earnings estimates. The Centers for Medicare & Medicaid Services released higher-than-expected 2027 rates for Medicare Advantage plans that are aimed at seniors, assuaging some investor concerns.

Seeking Alpha • May 20, 2026

AI Is Coming for Pharmacy Benefit Managers: Potential Winners and Losers

Pharmacy benefit managers (PBMs) sit at the chokepoint of U.S. drug distribution.

24/7 Wall Street • May 19, 2026

Elevance Health, Inc. (ELV) Shareholder/Analyst Call Prepared Remarks Transcript

Elevance Health, Inc. (ELV) Shareholder/Analyst Call Prepared Remarks Transcript

Seeking Alpha • May 13, 2026

Easing medical costs a positive for health insurers, but real test lies ahead, analysts say

U.S. health insurers' strong first-quarter results signaled more stable medical costs after prolonged pressure, but Wall Street analysts want to see another similar quarter before they are convinced.

Reuters • May 13, 2026

Health Insurers Performing Better But There's Potential Trouble Ahead

Health insurance companies including UnitedHealthcare, CVS Health's Aetna, Centene and Blue Cross and Blue Shield plans owned by Elevance Health are seeing lower costs from patients submitting claims.

Forbes • May 10, 2026

Major health insurers show signs of recovery – but a key test looms

Solid first-quarter results from major insurers like UnitedHealth, Elevance, Cigna and Humana have helped lift investor sentiment, even as insurers continue to grapple with higher medical costs. But analysts caution that insurers have incomplete data on medical costs in the first quarter due to a lag in claims processing, which sets up the second quarter as the real proving ground.

CNBC • May 5, 2026